China’s Gracell Biotechnologies Lists on Nasdaq

William Cao, founder and chief executive officer of Gracell Biotechnologies, discusses the Shanghai-based company’s initial public offering in the U.S. and its growth strategy. Gracell is developing …
( read original story …)